scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1019952369 |
P356 | DOI | 10.1186/1742-6405-3-21 |
P932 | PMC publication ID | 1609176 |
P698 | PubMed publication ID | 16970827 |
P5875 | ResearchGate publication ID | 6819846 |
P2093 | author name string | David Clifford | |
Lisa Mahnke | |||
P2860 | cites work | The immune epitope database and analysis resource: from vision to blueprint | Q24804461 |
How TCRs bind MHCs, peptides, and coreceptors | Q29619572 | ||
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy | Q33980528 | ||
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene | Q35020128 | ||
Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences | Q35149407 | ||
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. | Q36376216 | ||
Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. | Q36943282 | ||
Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells | Q39539955 | ||
Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes | Q40880429 | ||
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells | Q46577620 | ||
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study | Q46878731 | ||
Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes | Q47578453 | ||
Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1. | Q53850171 | ||
Evolution and transmission of stable CTL escape mutations in HIV infection | Q56880602 | ||
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia | Q57075698 | ||
HIV-specific cytotoxic T lymphocytes in seropositive individuals | Q59098667 | ||
QUASI analysis of the HIV-1 envelope sequences in the Los Alamos National Laboratory HIV sequence database: pattern and distribution of positive selection sites and their frequencies over yearsThis paper is one of a selection of papers in this Specia | Q59191806 | ||
HIV Drug Resistance | Q59448085 | ||
HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals | Q69022796 | ||
P304 | page(s) | 21 | |
P577 | publication date | 2006-09-14 | |
P1433 | published in | AIDS Research and Therapy | Q15755474 |
P1476 | title | Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation | |
P478 | volume | 3 |
Q39280285 | CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes |
Q28480902 | Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection |
Q28473296 | Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy |
Q41913817 | Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance |
Q35157869 | The association between HIV-1 subtype C antiretroviral resistance and HLA prevalence in southern India |
Q37077668 | Vaccination against drug resistance in HIV infection |